{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T14:19:48Z","timestamp":1788617988604,"version":"build-2803163510"},"reference-count":53,"publisher":"Japan Endocrine Society","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1507\/endocrj.ej26-0079","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T22:09:48Z","timestamp":1779833388000},"page":"1081-1090","source":"Crossref","is-referenced-by-count":2,"title":["Multimodal management of giant prolactinoma with extensive amyloid spherule deposition: a case report with review of the literature"],"prefix":"10.1507","volume":"73","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1747-1672","authenticated-orcid":false,"given":"Aysel","family":"Unver Ozkahraman","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Metabolism, University of Health Sciences, Basaksehir Cam and Sakura City Hospital, Istanbul, 34480, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7710-6239","authenticated-orcid":false,"given":"Merve","family":"Korkmaz Yilmaz","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, University of Health Sciences, Basaksehir Cam and Sakura City Hospital, Istanbul, 34480, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4217-2834","authenticated-orcid":false,"given":"Huseyin","family":"Karatay","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Health Sciences, Basaksehir Cam and Sakura City Hospital, Istanbul, 34480, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1633-9394","authenticated-orcid":false,"given":"Sidar","family":"Bagbudar","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Health Sciences, Basaksehir Cam and Sakura City Hospital, Istanbul, 34480, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4069-0021","authenticated-orcid":false,"given":"Ebubekir","family":"Akpinar","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University of Health Sciences, Basaksehir Cam and Sakura City Hospital, Istanbul, 34480, Turkey"},{"name":"Pituitary Disorders Application and Research Center (HATMER), University of Health Sciences, Istanbul, 34480, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8586-0613","authenticated-orcid":false,"given":"Buruc","family":"Erkan","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University of Health Sciences, Basaksehir Cam and Sakura City Hospital, Istanbul, 34480, Turkey"},{"name":"Pituitary Disorders Application and Research Center (HATMER), University of Health Sciences, Istanbul, 34480, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1631-8975","authenticated-orcid":false,"given":"Mehmet","family":"Karagulle","sequence":"additional","affiliation":[{"name":"Department of Radiology, University of Health Sciences, Basaksehir Cam and Sakura City Hospital, Istanbul, 34480, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1466-3887","authenticated-orcid":false,"given":"Mesut","family":"Yilmaz","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Department of Internal Medicine, University of Health Sciences, Bakirkoy Sadi Konuk Hospital, Istanbul, 34140, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mutlu","family":"Niyazoglu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, University of Health Sciences, Basaksehir Cam and Sakura City Hospital, Istanbul, 34480, Turkey"},{"name":"Pituitary Disorders Application and Research Center (HATMER), University of Health Sciences, Istanbul, 34480, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8361-8866","authenticated-orcid":false,"given":"Esra","family":"Hatipoglu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, University of Health Sciences, Basaksehir Cam and Sakura City Hospital, Istanbul, 34480, Turkey"},{"name":"Pituitary Disorders Application and Research Center (HATMER), University of Health Sciences, Istanbul, 34480, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Petersenn S, Fleseriu M, Casanueva FF, Giustina A, Biermasz N, et al. (2023) Diagnosis and management of prolactin-secreting pituitary adenomas: a pituitary society international consensus statement. Nat Rev Endocrinol 19: 722\u2013740.","DOI":"10.1038\/s41574-023-00886-5"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Chanson P, Maiter D (2019) The epidemiology, diagnosis and treatment of prolactinomas: the old and the new. Best Pract Res Clin Endocrinol Metab 33: 101290.","DOI":"10.1016\/j.beem.2019.101290"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Melmed S, Casanueva FF, Hoffman AR, Kleinberg DL, Montori VM, et al. (2011) Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96: 273\u2013288.","DOI":"10.1210\/jc.2010-1692"},{"key":"4","doi-asserted-by":"publisher","unstructured":"4 Molitch ME (2005) Pharmacologic resistance in prolactinoma patients. Pituitary 8: 43\u201352.","DOI":"10.1007\/s11102-005-5085-2"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Mete O, Cintosun A, Pressman I, Asa SL (2018) Epidemiology and biomarker profile of pituitary adenohypophysial tumors. Mod Pathol 31: 900\u2013909.","DOI":"10.1038\/s41379-018-0016-8"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Delgrange E, Trouillas J, Maiter D, Donckier J, Tourniaire J (1997) Sex-related difference in the growth of prolactinomas: a clinical and proliferation marker study. J Clin Endocrinol Metab 82: 2102\u20132107.","DOI":"10.1210\/jc.82.7.2102"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Colao A, Di Sarno A, Cappabianca P, Di Somma C, Pivonello R, et al. (2003) Withdrawal of long-term cabergoline therapy for tumoral and nontumoral hyperprolactinemia. N Engl J Med 349: 2023\u20132033.","DOI":"10.1056\/NEJMoa022657"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Szmygin H, Szyde\u0142ko J, Matyjaszek-Matuszek B (2022) Dopamine agonist-resistant microprolactinoma-mechanisms, predictors and management: a case report and literature review. J Clin Med 11: 3070.","DOI":"10.3390\/jcm11113070"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Pivonello C, Patalano R, Negri M, Pirchio R, Colao A, et al. (2021) Resistance to dopamine agonists in pituitary tumors: molecular mechanisms. Front Endocrinol (Lausanne) 12: 791633.","DOI":"10.3389\/fendo.2021.791633"},{"key":"10","unstructured":"10 Landolt AM, Kleihues P, Heitz PU (1987) Amyloid deposits in pituitary adenomas. Differentiation of two types. Arch Pathol Lab Med 111: 453\u2013458."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Hinton DR, Polk RK, Linse KD, Weiss MH, Kovacs K, et al. (1997) Characterization of spherical amyloid protein from a prolactin-producing pituitary adenoma. Acta Neuropathol 93: 43\u201349.","DOI":"10.1007\/s004010050581"},{"key":"12","unstructured":"12 Martin SW, Lefton DR, Pinto RS, Rosenblum M, Elowitz E (2002) MR imaging characteristics of amyloid deposits in pituitary adenoma. AJNR Am J Neuroradiol 23: 368\u2013370."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Prabhu S, Prabhu S (2019) Pituitary prolactinoma with amyloid deposits: surgery or dopamine agonists? Review of previous reports and new recommendations for management. Asian J Neurosurg 14: 754\u2013758.","DOI":"10.4103\/ajns.AJNS_127_19"},{"key":"14","doi-asserted-by":"publisher","unstructured":"14 Khaira M, Mutamba A, Meligonis G, Rose GE, Plowman PN, et al. (2008) The use of radiotherapy for the treatment of localized orbital amyloidosis. Orbit 27: 432\u2013437.","DOI":"10.1080\/01676830802350216"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Hall J, Rubinstein S, Lilly A, Blumberg JM, Chera B (2022) Treatment of localized amyloid light chain amyloidosis with external beam radiation therapy. Pract Radiat Oncol 12: 504\u2013510.","DOI":"10.1016\/j.prro.2022.03.011"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Niculescu DA, Gheorghiu ML, Poiana C (2023) Radiotherapy in aggressive or dopamine agonists resistant prolactinomas; is it still worthwhile? Eur J Endocrinol 188: R88\u2013R97.","DOI":"10.1093\/ejendo\/lvad044"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Barr R, Lampert P (1972) Intrasellar amyloid tumor. Acta Neuropathol 21: 83\u201386.","DOI":"10.1007\/BF00688003"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Bilbao JM, Kovacs K, Horvath E, Higgins HP, Horsey WJ (1975) Pituitary melanocorticotrophinoma with amyloid deposition. Can J Neurol Sci 2: 199\u2013202.","DOI":"10.1017\/S0317167100020266"},{"key":"19","unstructured":"19 Schober R, Nelson D (1975) Fine structure and origin of amyloid deposits in pituitary adenoma. Arch Pathol 99: 403\u2013410."},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Delafontaine P, Ochsner F, Pizzolato GP (1982) Pituitary adenoma with amyloid deposits and hyperprolactinemia. Case report and review. Acta Neuropathol 57: 81\u201384.","DOI":"10.1007\/BF00685373"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Osamura RY, Watanabe K, Komatsu N, Ohya M, Kageyama N (1982) Amorphous and stellate amyloid in functioning human pituitary adenomas: histochemical, immunohistochemical and electron microscopic studies. Acta Pathol Jpn 32: 605\u2013611.","DOI":"10.1111\/j.1440-1827.1982.tb02061.x"},{"key":"22","unstructured":"22 Bilbao JM, Horvath E, Hudson AR, Kovacs K (1975) Pituitary adenoma producing amyloid-like substance. Arch Pathol 99: 411\u2013415."},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Kuratsu J, Matsukado Y, Miura M (1983) Prolactinoma of pituitary with associated amyloid-like substances. Case report. J Neurosurg 59: 1067\u20131070.","DOI":"10.3171\/jns.1983.59.6.1067"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Paetau A, Partanen S, Mustajoki P, Valtonen S, Pelkonen R, et al. (1985) Prolactinoma of the pituitary containing amyloid. Acta Endocrinol (Copenh) 109: 176\u2013180.","DOI":"10.1530\/acta.0.1090176"},{"key":"25","doi-asserted-by":"publisher","unstructured":"25 Mori H, Mori S, Saitoh Y, Moriwaki K, Iida S, et al. (1985) Growth hormone-producing pituitary adenoma with crystal-like amyloid immunohistochemically positive for growth hormone. Cancer 55: 96\u2013102.","DOI":"10.1002\/1097-0142(19850101)55:1<96::AID-CNCR2820550116>3.0.CO;2-2"},{"key":"26","unstructured":"26 Kubota T, Kuroda E, Yamashima T, Tachibana O, Kabuto M, et al. (1986) Amyloid formation in prolactinoma. Arch Pathol Lab Med 110: 72\u201375."},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Bononi PL, Martinez AJ, Nelson PB, Amico JA (1993) Amyloid deposits in a prolactin-producing pituitary adenoma. J Endocrinol Invest 16: 339\u2013343.","DOI":"10.1007\/BF03348851"},{"key":"28","doi-asserted-by":"publisher","unstructured":"28 Sakai K, Tsutsui T, Sonobe H, Ohtsuki Y, Sawada A (1999) MRI of pituitary adenoma with extensive amyloid formation. Neuroradiology 41: 358\u2013359.","DOI":"10.1007\/s002340050765"},{"key":"29","unstructured":"29 Frankel KA (2000) Amyloid spherules in prolactinoma. Acta Cytol 44: 276\u2013277."},{"key":"30","unstructured":"30 Rane SR, Deshmukh SD, Bapat VM (2001) Amyloid (spheroid) deposits in pituitary adenoma presenting as Cushing disease\u2014a case report. Indian J Pathol Microbiol 44: 345\u2013346."},{"key":"31","doi-asserted-by":"crossref","unstructured":"31 Canda T, Sengiz S, Canda MS, Acar UD, Erbayraktar RS, et al. (2002) Histochemical and immunohistochemical features of a case showing association of meningioma and prolactinoma containing amyloid. Brain Tumor Pathol 19: 1\u20133.","DOI":"10.1007\/BF02482448"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32 Hassan T, Ikeda H, Yoshimoto T (2003) Salmon roe-like amyloid deposition in a prolactinoma: a case report. Brain Tumor Pathol 20: 89\u201392.","DOI":"10.1007\/BF02483453"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33 Wiesli P, Br\u00e4ndle M, Brandner S, Kollias SS, Bernays RL (2003) Extensive spherical amyloid deposition presenting as a pituitary tumor. J Endocrinol Invest 26: 552\u2013555.","DOI":"10.1007\/BF03345219"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34 Kim JH (2024) Reframing the paradigm: a nuanced approach to prolactinoma management. Endocrinol Metab (Seoul) 39: 850\u2013852.","DOI":"10.3803\/EnM.2024.2098"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35 Sung CO, Suh YL, Lee DK (2008) Extensive spherical amyloid deposition of pituitary adenoma presenting as pituitary apoplexy. Clin Neurol Neurosurg 110: 424\u2013425.","DOI":"10.1016\/j.clineuro.2007.12.017"},{"key":"36","unstructured":"36 Jim\u00e9nez L, Rivera ML, Ferr\u00e1 S, Col\u00f3n LE, Carro E (2008) Prolactinoma with extensive amyloid deposits: a case report. P R Health Sci J 27: 343\u2013345."},{"key":"37","doi-asserted-by":"publisher","unstructured":"37 Gul S, Bahadir B, Dusak A, Kalayci M, Edebali N, et al. (2009) Spherical amyloid deposition in a prolactin-producing pituitary adenoma. Neuropathology 29: 81\u201384.","DOI":"10.1111\/j.1440-1789.2008.00922.x"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38 Bakhtiar Y, Arita K, Hirano H, Habu M, Fujio S, et al. (2010) Prolactin-producing pituitary adenoma with abundant spherical amyloid deposition masquerading as extensive calcification. Neurol Med Chir (Tokyo) 50: 1023\u20131026.","DOI":"10.2176\/nmc.50.1023"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39 Kitamura K, Nakayama T, Ohata K, Wakasa K, Miki Y (2011) Computed tomography and magnetic resonance imaging appearance of prolactinoma with spheroid-type amyloid deposition. J Comput Assist Tomogr 35: 313\u2013315.","DOI":"10.1097\/RCT.0b013e31820d7bdf"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40 Levine SN, Ishaq S, Nanda A, Wilson JD, Gonzalez-Toledo E (2013) Occurrence of extensive spherical amyloid deposits in a prolactin-secreting pituitary macroadenoma: a radiologic-pathologic correlation. Ann Diagn Pathol 17: 361\u2013366.","DOI":"10.1016\/j.anndiagpath.2013.03.001"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41 Premalatha P, Venkata Renuka I, Rayapa Reddy T, Meghana A (2016) Amyloidogenic pituitary prolactinoma. Int J Otorhinolaryngol Head Neck Surg 5: 141\u2013144.","DOI":"10.4236\/ijohns.2016.53024"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42 Gupta M, Grover N, Sen R (2020) Spherical amyloid deposition in prolactinoma. Indian J Pathol Microbiol 63: 491\u2013492.","DOI":"10.4103\/IJPM.IJPM_178_19"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43 Divya M, Archana B, Cruze LD, Balasubramanian D (2024) Spherical type of amyloidogenic pituitary prolactinoma in a 50 year old male. Interdiscip Neurosurg 36: 101957.","DOI":"10.1016\/j.inat.2024.101957"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44 Singh AK, Shilpi, Kumari G, Tangri R (2024) Medically responsive amyloidogenic giant sellar-parasellar prolactinoma. Surg Neurol Int 15: 129.","DOI":"10.25259\/SNI_150_2024"},{"key":"45","doi-asserted-by":"publisher","unstructured":"45 Kreutz J, Vroonen L, Cattin F, Petrossians P, Thiry A, et al. (2015) Intensity of prolactinoma on T2-weighted magnetic resonance imaging: towards another gender difference. Neuroradiology 57: 679\u2013684.","DOI":"10.1007\/s00234-015-1519-3"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46 Asa SL, Mete O, Perry A, Osamura RY (2022) Overview of the 2022 WHO classification of pituitary tumors. Endocr Pathol 33: 6\u201326.","DOI":"10.1007\/s12022-022-09703-7"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47 Raverot G, Burman P, Abreu AP, Heaney AP, van Hulsteijn L, et al. (2025) Revised European Society of Endocrinology Clinical Practice Guideline for the management of aggressive pituitary tumours and pituitary carcinomas. Eur J Endocrinol 192: R45\u2013R78.","DOI":"10.1093\/ejendo\/lvaf100"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48 Raverot G, Burman P, McCormack A, Heaney A, Petersenn S, et al. (2018) European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomas. Eur J Endocrinol 178: G1\u2013G24.","DOI":"10.1530\/EJE-17-0796"},{"key":"49","doi-asserted-by":"publisher","unstructured":"49 Bertelsen C, Chadwick K, Holland J, Flint P, Schindler JS (2021) Long-term follow-up after radiation therapy for laryngeal amyloidosis. Laryngoscope 131: 1810\u20131815.","DOI":"10.1002\/lary.29061"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50 Almalki MH, Aljoaib NN, Alotaibi MJ, Aldabas BS, Wahedi TS, et al. (2017) Temozolomide therapy for resistant prolactin-secreting pituitary adenomas and carcinomas: a systematic review. Hormones (Athens) 16: 139\u2013149.","DOI":"10.14310\/horm.2002.1729"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51 Shimon I (2023) Prolactinomas resistant to dopamine agonists: pathophysiology and treatment. Arch Med Res 54: 102883.","DOI":"10.1016\/j.arcmed.2023.102883"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52 Akirov A, Rudman Y (2023) The role of aromatase inhibitors in male prolactinoma. J Clin Med 12: 1437.","DOI":"10.3390\/jcm12041437"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53 Gillam MP, Middler S, Freed DJ, Molitch ME (2002) The novel use of very high doses of cabergoline and a combination of testosterone and an aromatase inhibitor in the treatment of a giant prolactinoma. J Clin Endocrinol Metab 87: 4447\u20134451.","DOI":"10.1210\/jc.2002-020426"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/73\/9\/73_EJ26-0079\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T03:38:29Z","timestamp":1788579509000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/73\/9\/73_EJ26-0079\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":53,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej26-0079","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"EJ26-0079"}}